246 related articles for article (PubMed ID: 32788297)
1.
Caputo A; Liang Y; Raabe TD; Lo A; Horvath M; Zhang B; Brown HJ; Stieber A; Luk KC
eNeuro; 2020; 7(4):. PubMed ID: 32788297
[TBL] [Abstract][Full Text] [Related]
2. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
[TBL] [Abstract][Full Text] [Related]
3. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats.
Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P
Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094
[TBL] [Abstract][Full Text] [Related]
4. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.
Cole TA; Zhao H; Collier TJ; Sandoval I; Sortwell CE; Steece-Collier K; Daley BF; Booms A; Lipton J; Welch M; Berman M; Jandreski L; Graham D; Weihofen A; Celano S; Schulz E; Cole-Strauss A; Luna E; Quach D; Mohan A; Bennett CF; Swayze EE; Kordasiewicz HB; Luk KC; Paumier KL
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33682798
[TBL] [Abstract][Full Text] [Related]
6. Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils.
Zhang B; Kehm V; Gathagan R; Leight SN; Trojanowski JQ; Lee VM; Luk KC
Methods Mol Biol; 2019; 1948():45-57. PubMed ID: 30771169
[TBL] [Abstract][Full Text] [Related]
7. Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice.
Sano T; Nagata T; Ebihara S; Yoshida-Tanaka K; Nakamura A; Sasaki A; Shimozawa A; Mochizuki H; Uchihara T; Hasegawa M; Yokota T
Acta Neuropathol Commun; 2024 May; 12(1):75. PubMed ID: 38745295
[TBL] [Abstract][Full Text] [Related]
8. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT
Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665
[TBL] [Abstract][Full Text] [Related]
9. Aggregated Alpha-Synuclein Inclusions within the Nucleus Predict Impending Neuronal Cell Death in a Mouse Model of Parkinsonism.
Weston LJ; Bowman AM; Osterberg VR; Meshul CK; Woltjer RL; Unni VK
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499619
[TBL] [Abstract][Full Text] [Related]
10. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
Lashuel HA
Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.
Tenreiro S; Reimão-Pinto MM; Antas P; Rino J; Wawrzycka D; Macedo D; Rosado-Ramos R; Amen T; Waiss M; Magalhães F; Gomes A; Santos CN; Kaganovich D; Outeiro TF
PLoS Genet; 2014 May; 10(5):e1004302. PubMed ID: 24810576
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy.
Lin S; Leitão ADG; Fang S; Gu Y; Barber S; Gilliard-Telefoni R; Castro A; Sung K; Shen R; Florio JB; Mante ML; Ding J; Spencer B; Masliah E; Rissman RA; Wu C
Neurobiol Dis; 2023 Mar; 178():106010. PubMed ID: 36702318
[TBL] [Abstract][Full Text] [Related]
13. Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.
Luna E; Decker SC; Riddle DM; Caputo A; Zhang B; Cole T; Caswell C; Xie SX; Lee VMY; Luk KC
Acta Neuropathol; 2018 Jun; 135(6):855-875. PubMed ID: 29502200
[TBL] [Abstract][Full Text] [Related]
14. Alpha synuclein processing by MMP-3 - implications for synucleinopathies.
Bluhm A; Schrempel S; Moceri S; Stieler J; Feja M; Schilling S; Schulze A; von Hörsten S; Hartlage-Rübsamen M; Richter F; Roßner S
Behav Brain Res; 2022 Sep; 434():114020. PubMed ID: 35870616
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response.
Delaidelli A; Richner M; Jiang L; van der Laan A; Bergholdt Jul Christiansen I; Ferreira N; Nyengaard JR; Vægter CB; Jensen PH; Mackenzie IR; Sorensen PH; Jan A
Acta Neuropathol Commun; 2021 Jun; 9(1):105. PubMed ID: 34092244
[TBL] [Abstract][Full Text] [Related]
17. The expression level of alpha-synuclein in different neuronal populations is the primary determinant of its prion-like seeding.
Courte J; Bousset L; Boxberg YV; Villard C; Melki R; Peyrin JM
Sci Rep; 2020 Mar; 10(1):4895. PubMed ID: 32184415
[TBL] [Abstract][Full Text] [Related]
18. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.
Lázaro DF; Rodrigues EF; Langohr R; Shahpasandzadeh H; Ribeiro T; Guerreiro P; Gerhardt E; Kröhnert K; Klucken J; Pereira MD; Popova B; Kruse N; Mollenhauer B; Rizzoli SO; Braus GH; Danzer KM; Outeiro TF
PLoS Genet; 2014 Nov; 10(11):e1004741. PubMed ID: 25393002
[TBL] [Abstract][Full Text] [Related]
19. The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models.
Polinski NK; Martinez TN; Ramboz S; Sasner M; Herberth M; Switzer R; Ahmad SO; Pelligrino LJ; Clark SW; Marcus JN; Smith SM; Dave KD; Frasier MA
Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35419585
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
Svarcbahs R; Julku UH; Myöhänen TT
J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
